n(6)-carboxymethyllysine has been researched along with Atherosclerosis in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 10 (62.50) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Q; Fang, F; Ji, Y; Li, Y; Liu, W; Zhang, W | 1 |
| Bao, Z; Geng, Y; Jing, L; Li, L; Pang, Q; Shao, C; Sun, Z; Wang, Z; Yan, J; Zhang, L | 1 |
| Arai, T; Hoshi, T; Nishio, T; Nogami, M; Toukairin, Y | 1 |
| Bao, Z; Dai, Z; Jing, L; Li, L; Shao, C; Sun, Z; Wang, Z; Xu, S; Yan, J; Ye, F; Zhu, J | 1 |
| Feskens, EJM; Hanssen, NMJ; Schalkwijk, CG; Scheijen, JLJM; Stehouwer, CDA; Van der Kallen, CJ; van Greevenbroek, MM | 1 |
| Bengtsson, E; Blixt, O; Danielsson, L; Jansson, B; Nodin, B; Nordin Fredrikson, G; Persson, N; Risinger, C; Welinder, C; Wendel, U | 1 |
| Chen, X; Li, L; Liang, Y; Liu, N; Wang, Z; Yan, J; Yuan, W | 1 |
| Furuno, S; Kawakami, M; Kobayashi, Y; Muramatsu, M; Shirai, H; Takeuchi, M; Takino, J; Yamagishi, S | 1 |
| Chambless, LE; Couper, DJ; Duncan, BB; Heiss, G; Hoogeveen, RC; Luft, VC; Pankow, JS; Schmidt, MI | 1 |
| Bahn, G; Beisswenger, PJ; Howell, S; Reaven, PD; Saremi, A; Schwenke, DC | 1 |
| Basta, G; Castagnini, M; De Caterina, R; Del Turco, S; Epistolato, MC; Righini, P; Sangiorgi, GM; Tanganelli, P | 1 |
| Ang, A; Arab, L; Crasto, C; Dalal, M; Ferrucci, L; Jardack, P; Semba, RD; Talegawkar, S; Traber, MG | 1 |
| An, Y; Chen, D; Jiang, Y; Liu, N; Ren, L; Wang, Z; Zhu, Y | 1 |
| Matsui, J; Matsuki, K; Matsumura, K; Murakami, H; Suda, T; Tamasawa, N; Tanabe, J; Yamashita, M | 1 |
| Machado, AP; Moysés, ZP; Nakandakare, ER; Passarelli, M; Pinto, RS; Quintão, EC | 1 |
| Baynes, JW; den Hollander, NC; Graaff, R; Mulder, DJ; Smit, AJ; Smit, GP; Thorpe, SR | 1 |
16 other study(ies) available for n(6)-carboxymethyllysine and Atherosclerosis
| Article | Year |
|---|---|
Correlation Analysis of CML, sRAGE, and esRAGE and the Measure of Atherosclerosis of Coronary Heart Disease.
Topics: Atherosclerosis; Biomarkers; Coronary Disease; Glycation End Products, Advanced; Humans; Lysine; Receptor for Advanced Glycation End Products | 2022 |
N
Topics: Amputation, Surgical; Animals; Apolipoproteins E; Atherosclerosis; Cell Movement; Cells, Cultured; Diabetic Foot; Foam Cells; Humans; Lysine; Mice; Mice, Knockout; Proto-Oncogene Proteins c-vav; rac1 GTP-Binding Protein; Signal Transduction | 2020 |
Immunohistochemistry of advanced glycation end product N
Topics: Adult; Aged; Atherosclerosis; Atrial Remodeling; Autopsy; Coronary Vessels; Female; Fibrosis; Forensic Pathology; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lysine; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Natriuretic Peptides; Young Adult | 2020 |
CML/CD36 accelerates atherosclerotic progression via inhibiting foam cell migration.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; CD36 Antigens; Cell Migration Inhibition; Cell Movement; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Disease Progression; Foam Cells; Glycation End Products, Advanced; Lysine; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Plaque, Atherosclerotic; RAW 264.7 Cells | 2018 |
Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study.
Topics: Aged; Atherosclerosis; Body Mass Index; Cohort Studies; Diabetes Mellitus; Diet; Female; Food Handling; Glycation End Products, Advanced; Humans; Imidazoles; Lysine; Male; Middle Aged; Ornithine; Waist Circumference | 2018 |
A novel monoclonal antibody targeting carboxymethyllysine, an advanced glycation end product in atherosclerosis and pancreatic cancer.
Topics: Animals; Antibodies, Monoclonal; Atherosclerosis; Epitope Mapping; Female; Glycation End Products, Advanced; Humans; Lysine; Mice; Mice, Inbred BALB C; Pancreatic Neoplasms; Protein Array Analysis | 2018 |
Effects of Nε-carboxymethyl-Lysine on ERS-mediated apoptosis in diabetic atherosclerosis.
Topics: Animals; Apoptosis; Atherosclerosis; Blood Glucose; Blotting, Western; Cholesterol; Diabetes Mellitus, Experimental; Endoplasmic Reticulum Stress; Glycation End Products, Advanced; Immunohistochemistry; Lysine; Male; Mice | 2014 |
Assessment of the concentrations of various advanced glycation end-products in beverages and foods that are commonly consumed in Japan.
Topics: Antibodies; Atherosclerosis; Beverages; Biomarkers; Enzyme-Linked Immunosorbent Assay; Food Analysis; Glycation End Products, Advanced; Humans; Japan; Lysine; Risk Factors | 2015 |
Carboxymethyl lysine, an advanced glycation end product, and incident diabetes: a case-cohort analysis of the ARIC Study.
Topics: Atherosclerosis; Case-Control Studies; Cohort Studies; Diabetes Mellitus; Diabetic Angiopathies; Female; Glycation End Products, Advanced; Humans; Incidence; Lysine; Male; Middle Aged; Risk Factors | 2016 |
Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study.
Topics: Aged; Atherosclerosis; Blood Glucose; Carotid Intima-Media Thickness; Cholesterol; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glycation End Products, Advanced; Humans; Imidazoles; Lysine; Male; Middle Aged; Oxidation-Reduction; Pyruvaldehyde; Triglycerides | 2017 |
High plasma levels of the soluble receptor for advanced glycation endproducts in patients with symptomatic carotid atherosclerosis.
Topics: Aged; Aged, 80 and over; Atherosclerosis; C-Reactive Protein; Carotid Artery Diseases; Carotid Artery, Common; Carotid Stenosis; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Glycation End Products, Advanced; Humans; Immunohistochemistry; Linear Models; Lysine; Male; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2009 |
Dietary intake associated with serum versus urinary carboxymethyl-lysine, a major advanced glycation end product, in adults: the Energetics Study.
Topics: Adult; Aged; Atherosclerosis; Diabetes Mellitus; Diet; Female; Glycation End Products, Advanced; Humans; Kidney Diseases; Lysine; Male; Middle Aged; Young Adult | 2012 |
Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
Topics: Alkaline Phosphatase; Animals; Apolipoproteins E; Apoptosis; Atherosclerosis; Blotting, Western; Bone Morphogenetic Protein 2; Cell Differentiation; Cell Line; Core Binding Factor Alpha 2 Subunit; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diet, High-Fat; Disease Progression; Glucose; Immunohistochemistry; Injections, Intravenous; Lipoproteins, LDL; Lysine; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Osteogenesis; Rats; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Staining and Labeling; Time Factors; Vascular Calcification | 2012 |
Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes.
Topics: Aged; Apolipoprotein A-I; Aryldialkylphosphatase; Atherosclerosis; Biological Transport; Biomarkers; Cell Line; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Lipoproteins, HDL; Lysine; Macrophages; Male; Middle Aged; Serum Amyloid A Protein | 2013 |
Aminoguanidine and metformin prevent the reduced rate of HDL-mediated cell cholesterol efflux induced by formation of advanced glycation end products.
Topics: Albumins; Animals; Atherosclerosis; Cells, Cultured; Cholesterol, HDL; Diabetes Mellitus; Enzyme Inhibitors; Glycation End Products, Advanced; Guanidines; Humans; Hypoglycemic Agents; Lysine; Macrophages, Peritoneal; Metformin; Mice | 2006 |
Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia.
Topics: Adolescent; Adult; Arginine; Atherosclerosis; Carotid Arteries; Collagen; Female; Glycation End Products, Advanced; Glycogen Storage Disease Type I; Humans; Lysine; Male; Oxidative Stress; Risk; Skin; Tunica Intima; Tunica Media | 2007 |